Hair cortisol in pregnancy interacts with maternal depressive symptoms to predict maternal disrupted interaction with her infant at 4 months.


Journal

Developmental psychobiology
ISSN: 1098-2302
Titre abrégé: Dev Psychobiol
Pays: United States
ID NLM: 0164074

Informations de publication

Date de publication:
09 2020
Historique:
received: 04 05 2019
revised: 01 11 2019
accepted: 02 01 2020
pubmed: 11 2 2020
medline: 29 6 2021
entrez: 11 2 2020
Statut: ppublish

Résumé

Disrupted maternal interaction in early infancy is associated with maladaptive child outcomes. Thus, identifying early risk factors for disrupted interaction is an important challenge. Research suggests that maternal depressive symptoms and maternal cortisol dysregulation are associated with disrupted maternal interaction, but both factors have rarely been considered together as independent or interactive predictors of disrupted interaction. In a sample of 51 women, hair cortisol concentrations (HCC) and depressive symptoms were assessed during pregnancy, and depressive symptoms were assessed again at 4-month postpartum. Maternal disrupted interaction was assessed during the Still-Face Paradigm at 4 months. Results indicated that HCC and depressive symptoms interacted to predict both maternal withdrawing and inappropriate/intrusive interaction. Withdrawing interaction was associated with high levels of HCC in pregnancy in the context of high depressive symptoms at 4 months; inappropriate/intrusive interaction was associated with high levels of HCC in the context of low depressive symptoms. Thus, high HCC potentiated both forms of disrupted interaction. Results raised questions about the meaning of very low reported depressive symptoms, and underscored the importance of chronic stress physiology and maternal depressed mood as risk factors for distinct forms of maternal disrupted interaction, both of which are deleterious for infant development.

Identifiants

pubmed: 32037544
doi: 10.1002/dev.21950
pmc: PMC7415595
mid: NIHMS1598188
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-782

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD079484
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Psychoneuroendocrinology. 2015 Feb;52:289-96
pubmed: 25553388
Clin Psychol Rev. 2000 Nov;20(8):1019-40
pubmed: 11098398
J Child Psychol Psychiatry. 2000 Sep;41(6):737-46
pubmed: 11039686
Psychiatr Q. 1994 Winter;65(4):323-37
pubmed: 7831417
Infant Behav Dev. 2010 Dec;33(4):453-62
pubmed: 20554325
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3938-42
pubmed: 16495411
Diabetes Care. 2004 May;27(5):1066-70
pubmed: 15111522
Infant Ment Health J. 2007 May;28(3):314-323
pubmed: 28640469
J Clin Child Adolesc Psychol. 2006 Feb;35(1):116-26
pubmed: 16390307
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 1;928:1-8
pubmed: 23584040
J Clin Endocrinol Metab. 2006 Apr;91(4):1329-35
pubmed: 16434458
Int J Cogn Ther. 2012;5(3):316-329
pubmed: 25473440
Dev Psychopathol. 2004 Winter;16(1):1-18
pubmed: 15115062
Child Dev. 1990 Feb;61(1):85-98
pubmed: 2307048
Clin Psychol Rev. 2000 Aug;20(5):561-92
pubmed: 10860167
Dev Psychol. 2016 Jul;52(7):1073-87
pubmed: 27337514
Attach Hum Dev. 2006 Jun;8(2):89-111
pubmed: 16818417
Dev Psychol. 1997 Jul;33(4):681-92
pubmed: 9232383
Early Hum Dev. 2008 Jun;84(6):363-70
pubmed: 17988808
Infant Ment Health J. 2016 Mar-Apr;37(2):125-39
pubmed: 26939829
Psychosom Med. 2005 May-Jun;67 Suppl 1:S26-8
pubmed: 15953796
Compr Physiol. 2014 Jul;4(3):1273-98
pubmed: 24944037
New Dir Child Dev. 1986 Winter;(34):61-82
pubmed: 3822211
Physiol Behav. 2011 Aug 3;104(2):348-53
pubmed: 21397617
Forensic Sci Int. 2000 Jan 10;107(1-3):5-12
pubmed: 10689559
J Clin Endocrinol Metab. 2013 Jun;98(6):2573-80
pubmed: 23585660
PLoS One. 2013 Oct 18;8(10):e78103
pubmed: 24205112
Psychol Bull. 1988 Mar;103(2):265-275
pubmed: 3363047
Infant Behav Dev. 2011 Apr;34(2):248-56
pubmed: 21255845
Child Psychiatry Hum Dev. 2016 Oct;47(5):696-707
pubmed: 26521260
Psychol Bull. 1983 Jul;94(1):68-99
pubmed: 6353467
Annu Rev Clin Psychol. 2013;9:379-407
pubmed: 23394227
Arch Womens Ment Health. 2006 Nov;9(6):309-15
pubmed: 17013761
Arch Womens Ment Health. 2008 Jul;11(3):239-48
pubmed: 18493710
Neurosci Biobehav Rev. 2005 Apr;29(2):295-312
pubmed: 15811500
Attach Hum Dev. 2013;15(5-6):562-82
pubmed: 24299135
Clin Chim Acta. 2006 Aug;370(1-2):17-49
pubmed: 16624267
J Affect Disord. 2004 May;80(1):65-73
pubmed: 15094259
Harv Rev Psychiatry. 2009;17(2):147-56
pubmed: 19373622
J Abnorm Child Psychol. 2019 Feb;47(2):345-357
pubmed: 29959661
Attach Hum Dev. 2018 Dec;20(6):578-599
pubmed: 29374991
Dev Psychobiol. 2009 Dec;51(8):625-37
pubmed: 19739133
Psychoneuroendocrinology. 2005 Jul;30(6):541-9
pubmed: 15808923
Psychol Bull. 2007 Jan;133(1):25-45
pubmed: 17201569
Infant Behav Dev. 2017 May;47:92-102
pubmed: 28391126
Stress. 2018 Jan;21(1):43-50
pubmed: 29073819
Arch Womens Ment Health. 2016 Apr;19(2):219-27
pubmed: 26202722
Psychoneuroendocrinology. 2005 Oct;30(9):846-56
pubmed: 15961250
Borderline Personal Disord Emot Dysregul. 2018 Jan 22;5:2
pubmed: 29403645
Int J Neurosci. 2008 Aug;118(8):1181
pubmed: 18589921
Brain Behav Immun. 2012 Oct;26(7):1019-29
pubmed: 22366690
Psychoneuroendocrinology. 2019 May;103:104-117
pubmed: 30682626
Transl Psychiatry. 2015 Feb 17;5:e508
pubmed: 25689569
J Affect Disord. 2015 Apr 1;175:299-302
pubmed: 25661395
BMC Pregnancy Childbirth. 2016 May 31;16(1):124
pubmed: 27245670
Child Dev. 2013 Mar-Apr;84(2):528-42
pubmed: 23013523
Dev Psychobiol. 2009 Dec;51(8):650-61
pubmed: 19739135
Dev Psychobiol. 2019 May;61(4):543-556
pubmed: 30747450
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Psychoneuroendocrinology. 2013 Aug;38(8):1220-35
pubmed: 23253896
Midwifery. 2011 Dec;27(6):802-10
pubmed: 20888092
Psychol Bull. 2004 May;130(3):355-91
pubmed: 15122924
J Affect Disord. 1996 Jul 29;39(3):185-9
pubmed: 8856422
J Affect Disord. 2004 Jul;81(1):29-39
pubmed: 15183597
Psychosom Med. 1999 Mar-Apr;61(2):214-24
pubmed: 10204975
Psychoneuroendocrinology. 2019 Jan;99:216-224
pubmed: 30265918
J Abnorm Child Psychol. 2008 Feb;36(2):247-59
pubmed: 17805957
Dev Psychopathol. 2009 Spring;21(2):519-37
pubmed: 19338696
Child Dev. 1999 May-Jun;70(3):560-70
pubmed: 10368910
Monogr Soc Res Child Dev. 1999;64(3):67-96; discussion 213-20
pubmed: 10597543
Stress. 2012 May;15(3):348-53
pubmed: 22043813
J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):919-927
pubmed: 19625979
Behav Brain Res. 2019 Nov 18;374:112139
pubmed: 31381974
Psychoneuroendocrinology. 2012 May;37(5):589-601
pubmed: 21974976
Bull Menninger Clin. 2004 Fall;68(4):319-36
pubmed: 15843179
Child Dev. 1993 Apr;64(2):572-85
pubmed: 8477635
Psychopathology. 2016;49(4):285-294
pubmed: 27410251
Multivariate Behav Res. 1966 Apr 1;1(2):245-76
pubmed: 26828106
Infant Behav Dev. 2013 Jun;36(3):427-31
pubmed: 23632565
J Child Psychol Psychiatry. 2011 Apr;52(4):368-97
pubmed: 20925656
J Am Acad Child Psychiatry. 1978 Winter;17(1):1-13
pubmed: 632477
Infant Behav Dev. 2010 Feb;33(1):1-6
pubmed: 19962196
J Child Psychol Psychiatry. 1993 Oct;34(7):1083-101
pubmed: 8245134
Infant Behav Dev. 2008 Jan;31(1):92-106
pubmed: 17716739
Transl Psychiatry. 2017 Apr 25;7(4):e1103
pubmed: 28440816
Infancy. 2013 Nov;18(6):1111-1134
pubmed: 25506272
Psychoneuroendocrinology. 2018 Sep;95:145-148
pubmed: 29859342
Int J Ment Health Nurs. 2011 Oct;20(5):345-57
pubmed: 21385294
Psychoneuroendocrinology. 2017 Mar;77:261-274
pubmed: 28135674

Auteurs

Jennifer E Khoury (JE)

Harvard Medical School, Cambridge Hospital, Cambridge, MA, USA.

Michelle Bosquet Enlow (M)

Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Mariya C Patwa (MC)

Cambridge Hospital, Cambridge, MA, USA.

Karlen Lyons-Ruth (K)

Harvard Medical School, Cambridge Hospital, Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH